Stable Isotope Labelled Tildrakizumab Biosimilar – Anti-IL23A mAb – Research Grade

Reference: PX-TA1309-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Isotope Labelled Tildrakizumab Biosimilar - Anti-IL23A mAb - Research Grade
SourceCAS 1326244-10-3
SpeciesHumanized
Expression systemMammalian cells
Molecular weight144kDa
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsMS
Aliases /SynonymsMK-3222, SCH900222
ReferencePX-TA1309-SIL
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

Description of Tildrakizumab Biosimilar - Anti-IL23A mAb - Research Grade

General information on Anti-IL23A[Homo sapiens] (Tildrakizumab) Monoclonal Antibody

Tildrakizumab is a humanized IgG1 ? antibody that targets interleukin 23 p19 with high affinity. It is investigated for the treatment of chronic plaque psoriasis.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Isotope Labelled Tildrakizumab Biosimilar – Anti-IL23A mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below







    Cart (3 Items)

    Size:

    100ug

    Availability: In Stock
    1 × $411.00
    Size:

    100ug

    Availability: In Stock
    1 × $411.00
    size:

    100ug

    Availability: In Stock
    1 × $309.00